WIN-Partners Co., Ltd. (TYO:3183)

Market Cap	37.83B
Revenue (ttm)	81.41B
Net Income (ttm)	2.02B
Shares Out	28.60M
EPS (ttm)	70.44
PE Ratio	18.78
Forward PE	n/a
Dividend	51.00 (3.85%)
Ex-Dividend Date	Mar 28, 2025

Volume	21,200
Average Volume	24,205
Open	1,316.00
Previous Close	1,323.00
Day's Range	1,316.00 - 1,344.00
52-Week Range	1,012.00 - 1,595.00
Beta	0.16
RSI	56.00
Earnings Date	May 15, 2025

About WIN-Partners

WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1973
• Employees: 629
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 3183

Financial Performance

In 2024, WIN-Partners's revenue was 81.41 billion, an increase of 5.64% compared to the previous year's 77.06 billion. Earnings were 2.02 billion, an increase of 10.03%.